Your Cart
Your cart is currently empty.
Go to StoreItem | Price (USD) |
Announcing EmbracePlus, the ultimate medical wearable. Combining the precision of Empatica’s validated biomarkers with a beautiful design and on-wrist charging.
Every E4 purchased before the end of 2019 will be upgraded to EmbracePlus.
From Alzheimer’s, Parkinson's, Multiple Sclerosis, and Epilepsy, to Strokes, Brain Injuries, and Neuroinfectious Diseases. Neurological disorders affect and debilitate nearly one sixth of the world’s population, but research outside of the hospital remains extremely difficult.
EmbracePlus has been awarded a research grant by the Translational Research Institute for Space Health, who have partnered with NASA to address the protection of human health and performance across long-duration, deep space exploration missions.
EmbracePlus is the research infrastructure that empowers longitudinal studies through a fully flexible platform.
A broad range of validated biomarkers with real-time, objective data points.
Customizable sampling frequency through our SDK.
A beautiful watch with e-ink display and on-wrist charging that meets the needs of patients and researchers.
Built on the mobile and cloud data pipeline infrastructure of our FDA-cleared Embrace2, scaled to hundreds of thousands of users.
Continuous, hassle-free, and unobtrusive remote monitoring with no more need for on-site visits.
Direct integration of patient reported outcomes, collecting questionnaires and notifications through watch input.
EmbracePlus comes with a portable on-wrist charger, providing continuous data without obtrusive interruptions.
Leverage your research by using multiple clinically validated biomarkers or building your customized health application with our SDK.
EmbracePlus empowers neurological studies through the use of our clinically validated biomarkers.
EmbracePlus empowers third-party applications, leveraging a medical-grade platform for data collection, monitoring, and interaction with your customized mobile applications.
Sign up to receive EmbracePlus updates and news
Sign up to receive EmbracePlus updates and news